Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

In October 2013, we created a new, full-time position to lead our CR efforts. Juergen Brokatzky-Geiger, formerly Global Head of Human Resources and a member of the Executive Committee, took on this role effective in February 2014.

Dr. Matchaba describes how his unique background can help guide the company’s access-to-medicine efforts.

Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.

Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.

Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).

Jordan, a melanoma survivor, shares her experience with melanoma, BRAF mutation testing and the importance of patient empowerment.

Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.

Researchers race to put hydroxychloroquine to the test in a large study.

Explaining Chagas disease through the stories of patients in Latin America.